Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR

Overview of attention for article published in BMC Medicine, April 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 21 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 21,452 followers.

RT @BMCMedicine: Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant #chemotherapy in tri…

Reply Repost Favourite

RT @BMCMedicine: Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant #chemotherapy in tri…

Reply Repost Favourite

Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant #chemotherapy in triple-negative #breastcancer: Japan Breast Cancer Research Group (JBCRG)22 TR. Read it here: https://t.co/23KVZYEiSo https://t.co/QlTRO

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.